Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 8/2001

Content (6 Articles)

Original Article

Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus

Masato Okamoto, Go Ohe, Tetsuya Oshikawa, Sachiko Furuichi, Hidetomo Nishikawa, Tomoyuki Tano, Sharif Ahmed, Hideo Yoshida, Yoichiro Moriya, Motoo Saito, Mitsunobu Sato

Original Article

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2

Katrina T. Trevor, Evan M. Hersh, Jacquie Brailey, Jean-Marc Balloul, Bruce Acres

Original Article

Target cell induced activation of NK cells in vitro: cytokine production and enhancement of cytotoxic function

Suvendu Das, C. Varalakshmi, Leela A. Kumari, Megha Patel, Ashok Khar

Original Article

Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use

Radek Spisek, Laurent Bretaudeau, Isabelle Barbieux, Khaled Meflah, Marc Gregoire

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine